Insights

Strong Industry Position Cerner Enviza operates within the large and growing health technology sector, providing digital information systems tailored for hospitals and health systems, presenting opportunities to offer advanced healthcare IT solutions and integrations.

Strategic Acquisition Potential With Oracle's recent $28.3 billion acquisition of Cerner, there are significant opportunities to expand services, integrations, and solutions leveraging Oracle's comprehensive cloud infrastructure and data capabilities.

Cloud and Data Security Challenges Recent data breach lawsuits against Oracle highlight the importance of enhanced cybersecurity services, offering an opportunity to provide tailored security solutions to Cerner Enviza's clients or Oracle for fortifying health data protections.

Expanding Tech Collaborations Cerner Enviza's focus on real-world evidence and data-driven insights aligns with Oracle's AI and risk management awards, opening possibilities for joint solutions leveraging AI, cloud, and analytics for improved patient outcomes.

Growing Market Opportunities The company's engagement in international partnerships, including telecom and banking sectors, suggests potential for cross-industry solutions, particularly in IoT, 5G, and financial services, expanding the scope of sales discussions.

Cerner Enviza Tech Stack

Cerner Enviza uses 8 technology products and services including Oracle Service Cloud, Maximizer CRM, Istio, and more. Explore Cerner Enviza's tech stack below.

  • Oracle Service Cloud
    Contact Center Solutions
  • Maximizer CRM
    Customer Relationship Management
  • Istio
    Devops
  • JD Edwards
    Enterprise
  • Monica
    Generative Ai
  • Priority Hints
    Performance
  • three.js
    Programming Languages
  • VBScript
    Programming Languages

Media & News

Cerner Enviza's Email Address Formats

Cerner Enviza uses at least 2 format(s):
Cerner Enviza Email FormatsExamplePercentage
First.Last@cernerenviza.comJohn.Doe@cernerenviza.com
98%
F.Last@cernerenviza.comJ.Doe@cernerenviza.com
1%
First.M.Last@cernerenviza.comJohn.M.Doe@cernerenviza.com
1%
First.Last@oracle.comJohn.Doe@oracle.com
96%
Last.First@oracle.comDoe.John@oracle.com
2%
First-L@oracle.comJohn-D@oracle.com
1%
First.Middle.Last@oracle.comJohn.Michael.Doe@oracle.com
1%

Frequently Asked Questions

Where is Cerner Enviza's headquarters located?

Minus sign iconPlus sign icon
Cerner Enviza's main headquarters is located at 2800 Rockcreek Pkwy, Kansas City, Missouri 64117, US. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Cerner Enviza's official website and social media links?

Minus sign iconPlus sign icon
Cerner Enviza's official website is oracle.com and has social profiles on LinkedIn.

How much revenue does Cerner Enviza generate?

Minus sign iconPlus sign icon
As of October 2025, Cerner Enviza's annual revenue is estimated to be $38B.

What is Cerner Enviza's SIC code NAICS code?

Minus sign iconPlus sign icon
Cerner Enviza's SIC code is 7372 - Prepackaged Software NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Cerner Enviza have currently?

Minus sign iconPlus sign icon
As of October 2025, Cerner Enviza has approximately 501 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Head Of Services And Methods Europe: O. E.Global Head Of Qualitative Strategy, Cerner Enviza: J. H.Scientific Director: A. M.. Explore Cerner Enviza's employee directory with LeadIQ.

What industry does Cerner Enviza belong to?

Minus sign iconPlus sign icon
Cerner Enviza operates in the Research Services industry.

What technology does Cerner Enviza use?

Minus sign iconPlus sign icon
Cerner Enviza's tech stack includes Oracle Service CloudMaximizer CRMIstioJD EdwardsMonicaPriority Hintsthree.jsVBScript.

What is Cerner Enviza's email format?

Minus sign iconPlus sign icon
Cerner Enviza's email format typically follows the pattern of First.Last@cernerenviza.com. Find more Cerner Enviza email formats with LeadIQ.

How much funding has Cerner Enviza raised to date?

Minus sign iconPlus sign icon
As of October 2025, Cerner Enviza has raised $65M in funding. .
Cerner Enviza

Cerner Enviza

Research ServicesUnited States501-1000 Employees

Oracle has been a leader in life sciences for more than 40 years, igniting innovation through powerful and connected research, data, and technology. We deliver consultative end-to-end solutions and guidance throughout the therapeutic development lifecycle. Whether supporting the management of clinical trials and pharmacovigilance with market-leading tools, generating real-world evidence from unique data sets or guiding brand strategy with commercial insights, Oracle Life Sciences empowers the life sciences industry in its mission to improve patient outcomes. Learn more at oracle.com/life-sciences 

On December 20, 2021, Oracle and Cerner jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities.

Section iconCompany Overview

Headquarters
2800 Rockcreek Pkwy, Kansas City, Missouri 64117, US
Website
oracle.com
SIC Code
7372 - Prepackaged Software
NAICS Code
5417 - Scientific Research and Development Services
Employees
501-1000

Section iconFunding & Financials

  • $65M

    Cerner Enviza has raised a total of $65M of funding over 1 rounds. .

  • $10M$25M

    Cerner Enviza's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $65M

    Cerner Enviza has raised a total of $65M of funding over 1 rounds. .

  • $10M$25M

    Cerner Enviza's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.